Second Sight Medical Products Current Assets

Second Sight Medical Products (EYES) currently reports a current assets of $22M as of March 2026. That compares with $15M in the prior-year period — up 45.1% year over year. Use the charts on this page to explore Second Sight Medical Products's current assets history and peer comparisons.

Second Sight Medical Products's current assets increased from $15M to $22M — a 45.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Second Sight Medical Products reported $22M in current assets as of March 2026. That compares with $15M in the prior-year period — up 45.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Second Sight Medical Products, and consider following EYES for alerts when major investors trade the stock.

Second Sight Medical Products is classified in the Healthcare sector. On current assets, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EYES with unrelated industries.